VolitionRx Completes All Validation And Verification Of Chemiluminescent Immunoassay Version Of Nu.Q Vet Cancer Test With Fujifilm Vet Systems in Japan
Benzinga Newsdesk 8 months ago
News
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces the completion of all validation and verification of the chemiluminescent immunoassay (ChLIA) version of its Nu.Q®
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces the completion of all validation and verification of the chemiluminescent immunoassay (ChLIA) version of its Nu.Q® Vet Cancer Test with Fujifilm Vet Systems Co. Ltd ("Fujifilm Vet Systems") in Japan, allowing use of full automation rather than manual plates in central laboratories.